Somatostatinoma clinical trials

The registry lists 51 studies for Somatostatinoma across more than 10 countries. 2 are recruiting or about to start. 8 of them are mainly about Somatostatinoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02.

Get an email when these change. Save the Somatostatinoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 31
Terminated: 9
Withdrawn: 4
Active, not recruiting: 3
Recruiting: 2
Status unknown: 2

Phase

Phase 2: 33
Phase 1: 8
Phase 3: 3

Where

United States: 42
United Kingdom: 3
Spain: 3
Germany: 2
Canada: 2
France: 2

Who runs them

National Cancer Institute (NCI) (12) · ECOG-ACRIN Cancer Research Group (3) · Memorial Sloan Kettering Cancer Center (3) · Vanderbilt-Ingram Cancer Center (2) · Eastern Cooperative Oncology Group (2) · Yale University (2) · Mayo Clinic (2) · M.D. Anderson Cancer Center (2)

What is being tested here

Drugs under test in Somatostatinoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Phase 3	All
Capecitabine	0	5
Temozolomide	0	5
Everolimus	0	3
Bevacizumab	1	3
Vatalanib	0	2
Fluorouracil	0	2
Irinotecan	0	2
Leucovorin	0	2
Octreotide	0	2
Ipilimumab	0	1

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 10 · Antimetabolites 8 · Alkylating agents 6 · Angiogenesis inhibitors 5 · mTOR inhibitors 4

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Jun 2027Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" · M.D. Anderson Cancer Center
Aug 2027Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders · Mayo Clinic

Who these studies take

Of the 2 Somatostatinoma studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
Age	Women	Men
10	0 (0%)	0 (0%)
18	2 (100%)	2 (100%)
30	2 (100%)	2 (100%)
40	2 (100%)	2 (100%)
50	2 (100%)	2 (100%)
65	2 (100%)	2 (100%)
75	2 (100%)	2 (100%)
85	2 (100%)	2 (100%)

Across all 51 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 8% take children; 0% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 → or search them.